1. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives 
George Mastorakos, M.D., Carolina Koliopoulos, M.D., George Creatsas, M.D. 
Fertility and Sterility 
Volume 77, Issue 5, Pages (May 2002)
DOI: /S (02)02993-X

2. FIGURE 1
Ferriman-Gallway hirsutism score in the two groups of PCOS adolescent girls during the 12-month period of treatment with a combined oral contraceptive containing desogestrel (D, solid line) or cyproterone acetate (CA, dashed line). The asterisk indicates a statistically significant difference (P≤.05) from the baseline value of each group. NS indicates that the difference between the two groups was not statistically significant during the whole 12-month period of treatment. Statistical analysis was performed by ANOVA repeated measures. Values are given as mean ± SE.
Mastorakos. PCOS in adolescence. Fertil Steril 2002.
Fertility and Sterility  , DOI: ( /S (02)02993-X)

3. FIGURE 2
Serum triglyceride values in the two groups of PCOS adolescent girls during the 12-month period of treatment with a combined oral contraceptive containing desogestrel (D, solid line) or cyproterone acetate (CA, dashed line). The asterisk indicates a statistically significant difference (P≤.05) from the baseline value of each group. NS indicates that the difference between the two groups was not statistically significant during the whole 12-month period of treatment. Statistical analysis was performed by ANOVA repeated measures. Values are given as mean ± SE.
Mastorakos. PCOS in adolescence. Fertil Steril 2002.
Fertility and Sterility  , DOI: ( /S (02)02993-X)